824 related articles for article (PubMed ID: 18681215)
1. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
2. [The quest for an HIV vaccine].
Girard MP
Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
[TBL] [Abstract][Full Text] [Related]
3. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
4. AIDS vaccine development: the long and winding road.
Garber DA; Feinberg MB
AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
[TBL] [Abstract][Full Text] [Related]
5. HIV vaccine development: Lessons from the past, informing the future.
Bradac J; Dieffenbach CW
IDrugs; 2009 Jul; 12(7):435-9. PubMed ID: 19579164
[TBL] [Abstract][Full Text] [Related]
6. Development of prophylactic AIDS vaccines: the current state of affairs.
Hanke T
Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
[TBL] [Abstract][Full Text] [Related]
7. HIV vaccine development: a subtype E-specific strategy.
Brown AE; McNeil JG
Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):377-82. PubMed ID: 9886132
[TBL] [Abstract][Full Text] [Related]
8. [Development of an AIDS vaccine: status report].
Girard MP
Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
[TBL] [Abstract][Full Text] [Related]
9. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS.
Ahlers JD; Belyakov IM
Discov Med; 2010 Jun; 9(49):528-37. PubMed ID: 20587342
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.
Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Apr; 81(8):4137-44. PubMed ID: 17251297
[TBL] [Abstract][Full Text] [Related]
11. On modeling the effects of T-cell vaccines on HIV acquisition and disease.
Wick WD
Stat Med; 2008 Oct; 27(23):4805-16. PubMed ID: 18265425
[TBL] [Abstract][Full Text] [Related]
12. An HIV vaccine: how and when?
Esparza J
Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
[TBL] [Abstract][Full Text] [Related]
13. AIDS vaccines: concepts and first trials.
Sonigo P; Montagnier L; Tiollais P; Girard M
Immunodefic Rev; 1989; 1(4):349-66. PubMed ID: 2698645
[TBL] [Abstract][Full Text] [Related]
14. [HIV vaccine trials].
Ikuta K
Hokkaido Igaku Zasshi; 1993 Sep; 68(5):603-8. PubMed ID: 8225164
[TBL] [Abstract][Full Text] [Related]
15. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
16. Large HIV vaccine trial begins.
Santiago L
GMHC Treat Issues; 1998 Oct; 12(10):1-5. PubMed ID: 11365900
[TBL] [Abstract][Full Text] [Related]
17. New hope for an AIDS vaccine.
Robinson HL
Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
[TBL] [Abstract][Full Text] [Related]
18. Controversial HIV vaccine enters phase III trials amid skepticism.
AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
20. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
Sheppard N; Sattentau Q
Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
